Benjamin Perry
Fondateur chez MPC Therapeutics SA
Profil
Benjamin Perry has founded MPC Therapeutics SA in 2018, where he holds the title of Director.
Currently, he is working as a Principal at Medicxi Ventures (Jersey) Ltd.
since 2022.
Mr. Perry has a doctorate degree from Imperial College London, which he received in 2002, and a graduate degree from Swansea University, which he received in 1999.
Postes actifs de Benjamin Perry
Sociétés | Poste | Début |
---|---|---|
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Private Equity Investor | 01/11/2022 |
MPC Therapeutics SA
MPC Therapeutics SA BiotechnologyHealth Technology MPC Therapeutics SA is a company based in Plan-les-Ouates, Switzerland. The Swiss company was founded in 2018 by Benjamin Perry and has been led by CEO Raphael Martinou since its inception. | Fondateur | 01/01/2018 |
Formation de Benjamin Perry
Imperial College London | Doctorate Degree |
Swansea University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Finance |
MPC Therapeutics SA
MPC Therapeutics SA BiotechnologyHealth Technology MPC Therapeutics SA is a company based in Plan-les-Ouates, Switzerland. The Swiss company was founded in 2018 by Benjamin Perry and has been led by CEO Raphael Martinou since its inception. | Health Technology |